Transactions & Cases Detail



Transaction/Case Details

ConjuChem announces completion of C$5 million non-dilutive capital transaction

DATE CLOSED

August 25, 2009

BUSINESS SECTOR

Pharmaceutical / Bio Life Sciences

LEAD OFFICE

Montreal

VALUE

5 Million CAD


OVERVIEW

On August 25, 2009, ConjuChem Biotechnologies Inc. ("ConjuChem") announced the completion of the transaction providing C$5 million in new, non-dilutive capital to the Company. The Superior Court of Québec has approved the previously announced plan of arrangement (the "Arrangement") under section 192 of the Canada Business Corporations Act (the "CBCA") involving ConjuChem and Colabor Income Fund ("Colabor"), among others, all as fully described in ConjuChem's management information circular dated July 17, 2009.

As part of the transaction, ConjuChem will carry on its business operations as they existed immediately prior to the Arrangement in a new entity, named "ConjuChem Biotechnologies Inc.", owned by the former shareholders of ConjuChem, but with the additional cash received from Colabor.

McCarthy Tétrault LLP represented ConjuChem, with a team co-led by Clemens Mayr and Philippe Leclerc.

Contact


 
For general information on McCarthy Tétrault Transactions & Cases, please contact [email protected].

Related Area of Expertise


Continuous Disclosure
read /

Corporate Commercial Litigation
read /

Corporate Governance
read /

Intellectual Property
read /

Litigation
read /

M&A
read /

Pharmaceutical
read /

Public Companies
read /

Securities Litigation
read /

Technology & Licensing
read /